Table 3.
Annual Reported Cases of Neonatal Tetanus and TT2 Coverage for Countries Completing Regional PsA-TT Campaigns in 1- to 29-Year-Olds by 2012
| Country | Partial Campaign Year | 2009 |
2010 |
2011 |
2012 |
2013 |
|||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NT Cases | NT Coverage Estimate, % | NT Cases | NT Coverage Estimate, % | NT Cases | NT coverage Estimate, % | NT Cases | NT Coverage Estimate, % | NT Cases | NT Coverage Estimate, % | ||
| Cameroon | 2011 | 39 | 91 | 29 | 91 | 31 | 75 | 23 | 85 | 43 | 85 |
| Togo | 2012 | 17 | 81 | 28 | 81 | 28 | 81 | 20 | 81 | 26 | 77 |
| Benin | 2012 | 4 | 92 | 3 | 92 | 6 | 92 | 4 | 93 | 8 | 93 |
| Ghana | 2012 | 8 | 86 | 1 | 86 | 5 | 88 | 0 | 88 | 1 | 88 |
| Total | 68 | 61 | 70 | 47 | 78 | ||||||
Post–PsA-TT campaign data are shown in bold.
Abbreviations: NT, neonatal tetanus; PsA-TT, group A meningococcal conjugate vaccine; TT2, second dose of tetanus toxoid.